GlassScriptPhysician profile
Edwin A Esquibel
NPI 1245331123
$5,609.04
in general payments reported to CMS, 2019-2025
7 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $1,561 · 2023: $2,893 · 2024: $636 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855 · Travel and Lodging: $1,839 · Education: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,854.54 |
| Travel and Lodging | $1,839.19 |
| Education | $229.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,134.84 | 2022-2025 | Inspire |
| Zoll Respicardia, INC. | $1,782.25 | 2023-2025 | Remede System |
| Harmony Biosciences LLC | $436.88 | 2021-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $138.41 | 2021-2024 | |
| Glaxosmithkline, LLC. | $67.98 | 2021 | |
| Resmed Corp | $34.33 | 2025 | |
| Vanda Pharmaceuticals INC. | $14.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Esquibel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.